Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Long term relief from arthritis could evolve from B-cell targeted treatments

Long term relief from arthritis could evolve from B-cell targeted treatments

June 14, 2004

Long term relief for arthritis sufferers could be one step closer, thanks to a study of B-cell targeted therapy published today. The study from UCL reveals a major but hitherto poorly acknowledged role for B-cells in the most common and severe form of arthritis to affect younger people. By targeting B-cells, which are part of the body's immune system, it may be possible to break a key vicious cycle underlying the disease.

The drug trial, led by UCL Professor Jonathan Edwards, published today in the New England Journal of Medicine, explored the possibility of using a one-off drug treatment to banish the symptoms of rheumatoid arthritis form the body for months or years, with the ultimate aim of permanent relief, rather than relying on continuous drug therapy.

Of 161 patients involved in the study, 43% of those receiving a short course of B cell targeted therapy based on the drug rituximab found arthritic symptoms such as joint pain, swelling and stiffness were reduced by more than half as measured six months later, compared with 13% in the control group who took conventional drugs only.

The study was designed to assess improvement over six months but it was found that in many cases improvement was maintained for at least a year, confirming pilot studies at UCL suggesting an average benefit lasting over a year and sometimes as long as three years.

Previous laboratory research at UCL had led Professor Edwards and colleague Dr Jo Cambridge to suggest that antibodies directed against the body's own proteins might not only cause inflammation in rheumatoid arthritis but might also create a vicious cycle driving the disease on. Antibodies are made by B-cells and the idea was put forward that removing B-cells might cause the cycle, and the disease, to collapse.

Experience at UCL indicates that permanent relief from a single course of treatment is not yet possible. However, the fact that improvement can last for a period of years suggests that the approach is on the right track. Moreover, studies from UCL and elsewhere in other autoimmune diseases such as lupus are producing similar results.

Professor Edwards says: "This study provides clear evidence for the importance of B-cells in rheumatoid arthritis, heralding a major shift in our understanding of the disease.

"The cycle underlying autoimmune diseases such as rheumatoid arthritis may be similar to a bug in a computer that makes it loop and crash. B-cell targeted therapy is like rebooting the computer of your immune system to sidestep the bug.

"As is often the case, if you have not removed the bug completely the computer system may crash again. This seems to be where we are at present, possibly because the current treatment does not remove more than 80 to 90 per cent of B-cells, where the ideal treatment would knock out 100 per cent of cells.

"The challenge is to break the cycle once and for all. Many different B-cell targeted drugs are now in development and I am optimistic that long term benefit from a single treatment is achievable.

"People with arthritis desperately want to be free of painful, sleepless nights and fatigue and stiffness in the day. They also want to be free from the burden of long term drug treatment. This is what we should be aiming for."

Around a billion B-cells, or lymphocytes, are created every day by the body's immune system. B-cells generate antibodies to help fight infections. Each B-cell makes a different antibody by shuffling its antibody genes. B-cells that by chance make antibodies to the body's own proteins normally disappear. However, very rarely it seems that they can set up the vicious cycle that allows them to grow and produce damaging effects, known as autoimmunity.

Current B-cell targeted therapy works by knocking out 'bad' B-cells, but also knocks out useful B-cells for a period of months. The effect on 'bad' antibodies is greater than on useful antibodies but after repeated treatments levels of useful antibodies may be reduced.

This suppression of the useful side of the immune system, with a risk of infections, is a common problem with treatments for autoimmune disease. Experience at UCL suggests that chest infection may be more common during the months after B-cell targeted treatment.

For this reason further studies are needed to ensure the treatment is as safe as possible. It is also an incentive to develop B cell targeted therapy either to remove only disease-related B-cells or to ensure that treatment is powerful enough to avoid the need for repeated courses.

University College London - UCL




Related Immune System Current Events and Immune System News Articles Immune System Current Events and Immune System News RSS Immune System Current Events and Immune System News RSS
Evolution in action: Our antibodies take 'evolutionary leaps' to fight microbes
With cold and flu season in full swing, the fact that viruses and bacteria rapidly evolve is apparent with every sneeze, sniffle, and cough. A new report in the January 2009 issue of The FASEB Journal, explains for the first time how humans keep up with microbes by rearranging the genes that make antibodies to foreign invaders. This research fills a significant gap in our understanding of how the immune system helps us survive.

Understanding Extinct Microbes May Influence the State of Modern Human Health
The study of ancient microbes may not seem consequential, but such pioneering research at the University of Oklahoma has implications for the state of modern human health. Cecil Lewis, assistant professor in the Department of Anthropology, says results of this research raise questions about the microbes living on and within people.

Lung cancer cells activate inflammation to induce metastasis
A research team from the University of California, San Diego School of Medicine has identified a protein produced by cancerous lung epithelial cells that enhances metastasis by stimulating the activity of inflammatory cells.

Researchers engineer pancreatic cell transplants to evade immune response
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.

Salk researchers develop novel glioblastoma mouse model
Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma-the most common and deadly brain cancer in humans-that closely resembles the development and progression of human brain tumors that arise naturally.

Immune cells contribute to the development of Parkinson's disease
Parkinson disease is a neurodegenerative disorder that impairs movement, balance, speech, and other functions. It is characterized by the loss of nerves in the brain that produce a substance known as dopamine.

Redesigned protein accelerates blood clotting
Researchers have made several, subtle changes in the structure of a key protein, dramatically increasing its ability to drive blood clotting, according to a study published in a December edition of the Journal of Thrombosis and Haemostasis.

Biomedical researchers create artificial human bone marrow in a test tube
Artificial bone marrow that can continuously make red and white blood cells has been created in a University of Michigan lab.

Peering inside the skull of a mouse to solve meningitis mystery
NYU Langone Medical Center scientists and their collaborators at the Scripps Research Institute in La Jolla, Calif., have discovered an unexpected cause for the fatal seizures seen in mice with viral meningitis, an infection of the central nervous system, according to a study published in the journal Nature.

Breathing life into injured lungs: World-first technique will expand lung donor organ pool
For the first time in the world, transplant surgeons at Toronto General Hospital, University Health Network used a new technique to repair an injured donor lung that was unsuitable for transplant, and then successfully transplanted it into a patient.
More Immune System Current Events and Immune System News Articles


The Immune System
by Peter Parham

The Immune System, Second Edition has been designed for use in immunology courses for undergraduate, medical, dental, and pharmacy students. This class-tested and successful textbook synthesizes the established facts of immunology into a comprehensible, coherent, and up-to-date account of how the immune system works, rather than presenting immunology as a chronology of experiments and ...



How the Immune System Works (Blackwell's How It Works)
by Lauren M. Sompayrac

Understanding the immune system is crucial for both medical and bioscience students, with new research revealing yet more secrets year on year. Many books offer in-depth introductions to the subject, but How the Immune System Works remains uniquely popular for its personable and practical overview of the nuts and bolts of the immune system.This third edition provides a perfect introduction to the...



90-Day Immune System Makeover
by Janet C. Maccaro

No matter how your health has been in the past, there is something you can do right now—a complete makeover to give you the vitality and energy to embrace life at your best! In just ninety days, Janet Maccaro will enable you to build and strengthen your immune system to bring your body into proper balance and experience disease-free living. Birthed out of Maccaro’s twenty-year struggle with...



The Immune System Cure: Optimize Your Immune System in 30 Days-The Natural Way!



Basic Immunology: Functions and Disorders of the Immune System
by Abul K. Abbas, Andrew H. Lichtman

Univ. of California, San Francisco. Revised edition presents new advancements in the understanding of the immune system. Topics covered include effector mechanisms of cell-mediated immunity, humoral immune responses, innate immunity, antigen recognition, and more. Utilizes case studies. Previous edition not cited....



Boost Your Child's Immune System: A Program and Recipes for Raising Strong, Healthy Kids
by Lucy Burney

Ideal for all parents, whatever their children's age—how to help kids be fit and strong for life, from a top nutrition specialist. Making the most of superfoods and nutrients, this powerful guide gives parents the building blocks and a clear plan to raise kids who are fit and strong for life and capable of fighting off bugs and infections. Top nutrition specialist Lucy Burney walks parents...



Maximum Healing: Improve Your Immune System and Optimize Your Natural Ability to Heal
by H. Robert Silverstein, Tom Monte

If you suffer from—allergies, asthma, high blood pressure or cholesterol, cancer, chronic fatigue, headaches, heart disease, joint pain, skin disorder, or rheumatoid arthritis—then this may be the most important book you will ever read. Inspiring case histories demonstrate successful treatment and prevention of these and many other...



The Top 100 Immunity Boosters: 100 Recipes to Keep Your Immune System Fighting Fit
by Charlotte Haigh

A vigorous immune system is vital to good health, both physical and mental. Research has long shown that the nutrients present in common foods can help strengthen the body’s natural defenses and provide unbeatable protection against infection, disease, and allergy. This handy guide lists the most potent of these immune-boosting foods – profiling each one, highlighting its unique benefits, and...



Double the Power of Your Immune System
by John Heinerman

This layperson's guide tells how to combat the threats of diets loaded with processed foods, polluted environments, and stressful life styles with immunity-building foods, herbs, spices, and life style and environmental changes. From the common cold to arthritis, Double the Power of Your Immune System gives specific advice on overcoming a host of ills through enhanced immune...



Artificial Immune Systems: 7th International Conference, ICARIS 2008, Phuket, Thailand, August 10-13, 2008, Proceedings (Lecture Notes in Computer Science)

This book constitutes the refereed proceedings of the 7th International Conference on Artificial Immune Systems, ICARIS 2008, held in Phuket, Thailand, in August 2008. The 40 revised full papers presented were carefully reviewed and selected from 67 submissions. The papers are organized in topical sections on computational immunology, applied AIS, and theoretical AIS. Position papers and...

© 2009 BrightSurf.com